References
- National Cancer Institute Monograph No 81–2330, J L Young, Jr, et al. National Institutes of Health, Bethesda, MD 1981
- Newell G R, . Cancer: Principles and Practice of Oncology, V T Devita, S Hellman, S A Rosenberg, et al. JB Lippincott, Philadelphia 1982
- Witten M. Modeling of the aging-cancer interface: Some thoughts on a complex biological dynamics. J Gerontol Biol Sci 1989; 44: 72–80
- Peto R, Roe F JC, Lee P N, et al. Cancer and aging in mice and men. Br J Cancer 1975; 32: 411–426
- Weksler M E, Innes J B, Golstein G. Immunologic study of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal by thymopoietin. Small Low Cyplers 32–36. J Exp Med 1978; 148: 996–1006
- Gottesman S R, Kristie J A, Walford R L. Proliferative and cytotoxic immune functions in aging mice. I. Sequence of decline of reactivities measured under optimal and suboptimal sensitization conditions. Immunology 1981; 44: 607–616
- Maher V N, McCormik J J. Role of DNA lesions and repair in the transformation of human cells. Pharmacol Ther 1984; 25: 395–408
- Alessio H, Cutler R G. Average rate of oxyradical oxidation of deoxyguanosine in DNA of mammalian species is proportional to their aging rate. Gerontologist 1987; 27: 151A
- Kaesberg P R, Ershler W B. The importance of immunosenescence in the incidence and malignant properties of cancer in hosts of advanced age. J Gerontol Biol Sci 1989; 44: 63–66
- Schottenfeld D, Robbins G F. Breast cancer in elderly women. Geriatrics 1971; 26: 121–131
- Calabrese C T, Adams Y G, Volk H. Geriatric colon cancer. Am J Surg 1973; 125: 181–184
- Herbsman H, Feldman J, Seldera J, et al. Survival following breast cancer surgery in the elderly. Cancer 1981; 47: 2358–2363
- Ershler W B, Socinski M A, Greene C J. Bronchogenic cancer. Metastasis and aging. J Am Geriatr Soc 1983; 31: 673–676
- Ershler W B. Why tumors grow more slowly in old people. J Natl Cancer Inst 1986; 77: 837–839
- Ershler W B, Stewart J A, Hacker M P, et al. B16 murine melanoma and aging-Slower growth and longer survival in old mice. J Natl Cancer Inst 1984; 72: 161–164
- Leibovici J. Serial passages of tumors in mice in the study of tumor progression and testing of antineoplastic drugs. Cancer Res 1984; 44: 1981–1984
- Leibovici J, Kopel S, Wolman M. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide. Anticancer Res 1985; 5: 553–558
- Leibovici J, Michowitz M, Argaman H, et al. A model for cancer therapy in advanced compared to early cancer. Anticancer Res 1986; 6: 1225–1230
- Michowitz M, Klein O, Sharabi Y, et al. AKR lymphoma malignancy variants differing at late phase of metastasis. Cancer Lett 1990; 2: 39–47
- Leibovici J, Michowitz M, Argaman H. Change in the role of the spleen from protective to harmful following tumor progression in AKR lymphoma. Invas Metast 1990; 10: 289–300
- Kopel S, Michowitz M, Leibovici J. Effect of splenectomy on the efficiency of chemo-immunotherapy of melanoma-bearing mice. Int J Immunopharmacol 1985; 7: 801–810
- Leibovici J, Michowitz M, Hoenig S, et al. Different host reactions and response to immunotherapy of the F1 and F10 variants of B16 melanoma. 7th Eur Immun Meet, Jerusalem, 1985; 211
- Wasserman L, Nordenberg J, Kronfeld H, et al. Isolation and Characterization of a Drug-Resistant Melanoma Cell Line and Reduction of Drug Resistance by the Antibiotic Drug Novobiocin. Baki Clin Biochem Lab Science, Haifa 1992; 18
- Morfandini S, Yancik R. Cancer in the elderly: Meeting the challenge of an aging population. J Natl Cancer Inst 1993; 85: 532–538
- Clark W H, Jr. Pathology, E Rubin, J L Farber. JB Lippincott, Philadelphia 1988; 1242
- Leibovici J. A Model for the study of the long duration pathogenesis of cancer and its relevance to therapy. Med Hypoth 1983; 10: 105–112
- Jain R K. Determinants of tumor blood flow: A review. Cancer Res 1988; 48: 2641–2658
- Jain R K. Barriers to drug delivery in solid tumors. Sci Am July, 1994; 271: 58–65